Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data.

Osman SütçüoğluAkif DoğanFunda YılmazAhmet Bilgehan ŞahinTaha Koray ŞahinSelin Aktürk EsinCihan ErolAytuğ ÜnerAhmet ÖzetNedim TuranEmrah EraslanAdem DeligönülHatice OdabaşNazan GünelGökhan UçarDidem Şener DedeÖmer DizdarErdem ÇubukçuÖmür Berna ÖksüzoğluMahmut Emre YıldırımOzan YazıcıNuriye Özdemir

Published in: Pancreas (2023)

In conclusion, it has been shown that gemcitabine-based second-line treatments contribute to survival in patients with advanced pancreatic cancer. In addition, there was no difference in efficacy between gemcitabine monotherapy or combination treatments.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
radiation therapy
combination therapy
big data
free survival
deep learning
study protocol